Source: Pasman, E., Kollin, R., Broman, M. et al. Cumulative barriers to retention in methadone treatment among adults from rural and small urban communities. Addict Sci Clin Pract 17, 35 (2022). https://doi.org/10.1186/s13722-022-00316-3 Abstract Background Though methadone has been shown to...

Source: Le TT, Park S, Choi M, et al. Respiratory events associated with concomitant opioid and sedative use among Medicare beneficiaries with chronic obstructive pulmonary disease. BMJ Open Respiratory Research 2020;7:e000483. doi: 10.1136/bmjresp-2019-000483 Abstract Background Opioids and...

Source: Shorter, G. W., Harris, M., McAuley, A., Trayner, K. M., & Stevens, A. (2022). The United Kingdom's first unsanctioned overdose prevention site; A proof-of-concept evaluation. International Journal of Drug Policy, 104, 103670. Abstract Background The United Kingdom (UK) is currently...

Source: Yang Lim, T, et al. (2022). Modeling the evolution of the US opioid crisis for national policy development. Proceedings of the National Academy of Sciences, 119(23). https://www.pnas.org/doi/10.1073/pnas.2115714119 Significance The opioid crisis remains one of the greatest public health...

Source: Heikkinen, M., Taipale, H., Tanskanen, A., Mittendorfer‐Rutz, E., Lähteenvuo, M., & Tiihonen, J. (2022). Real‐world effectiveness of pharmacological treatments of opioid use disorder in a national cohort. Addiction. Abstract Aim To investigate the real-world effectiveness of pharmacological...

Source: Janzow, G. E., Harding, C., Flores, M., Borodovsky, J., Steinkamp, J., Marsch, L. A., & Schuman-Olivier, Z. (2022). Assessing the feasibility, usability and acceptability of the MySafeRx platform among individuals in outpatient buprenorphine treatment: Lessons learned from a pilot randomized...

Source: Romero-Mendoza, M., Peláez-Ballestas, I., Almanza-Avendaño, A.M. et al. Structural violence and the need for compassionate use of methadone in Mexico. BMC Public Health 22, 606 (2022). https://doi.org/10.1186/s12889-022-12955-x Abstract Background Epidemiological data from Mexico have...

Source: Ospina-Escobar, A., & Magis-Rodríguez, C. (2022). Transition from first illegal drug use to first injection among people who inject drugs in Northern Mexico: A retrospective survival analysis. Salud Mental, 45(2), 71-80. doi:https://doi.org/10.17711/SM.0185-3325.2022.010 Abstract...

Source: L.Driscoll, D., Cuellar, A.E., Agarwal, V. et al. Promoting sustainable responses to the US opioid epidemic with community-academic partnerships: qualitative outcomes from a statewide program. Subst Abuse Treat Prev Policy 17, 26 (2022). https://doi.org/10.1186/s13011-022-00454-6 Abstract...

Source: Dietze, P., Gerra, G., Poznyak, V., Campello, G., Kashino, W., Dzhonbekov, D., Kiriazova, T., Nikitin, D., Terlikbayeva, A., Krupchanka, D., & Busse, A. (2022). An observational prospective cohort study of naloxone use at witnessed overdoses, Kazakhstan, Kyrgyzstan, Tajikistan, Ukraine...

Source: Yunusa I, Gagne JJ, Yoshida K, Bykov K. Risk of Opioid Overdose Associated With Concomitant Use of Oxycodone and Selective Serotonin Reuptake Inhibitors. JAMA Netw Open. 2022;5(2):e220194. doi:10.1001/jamanetworkopen.2022.0194 Key Points Question Is concomitant use of oxycodone with...

Source: Ericson, Ø.B., Eide, D., Lobmaier, P. et al. Staff preferences towards electronic data collection from a national take-home naloxone program: a cross-sectional study. Subst Abuse Treat Prev Policy 17, 13 (2022). https://doi.org/10.1186/s13011-022-00440-y Abstract Background During the...

Fonte: Currie JM, Schnell MK, Schwandt H, Zhang J. Prescrição de Analgésicos Opioides e Buprenorfina para Transtorno de Uso de Opioides Durante o COVID-19 Pandmic. JAMA Netw Open. 2021;4(4):e216147. doi:10.1001/jamanetworkopen.2021.6147 Pontos-chave Pergunta Como a prescrição de analgésicos opioides...

Source: Thakrar AP, Alexander GC, Saloner B. Trends in Buprenorphine Use in US Jails and Prisons From 2016 to 2021. JAMA Netw Open. 2021;4(12):e2138807. doi:10.1001/jamanetworkopen.2021.38807 Discussion In the US, buprenorphine use increased substantially in correctional settings during the past 5...

Source: Levander, X.A., Hoffman, K.A., McIlveen, J.W. et al. Rural opioid treatment program patient perspectives on take-home methadone policy changes during COVID-19: a qualitative thematic analysis. Addict Sci Clin Pract 16, 72 (2021). https://doi.org/10.1186/s13722-021-00281-3 Abstract Background...

Fonte: https://www1.nyc.gov/assets/doh/downloads/pdf/public/supervised-injection-report.pdf Publicado em 05/03/2018 As mortes por overdose em Nova York aumentaram constantemente nos últimos 15 anos, crescendo para a crise que enfrentamos agora. Em 2017, dados provisórios confirmaram 1.441 mortes por...

Source: Frost, M.C., Lampert, H., Tsui, J.I. et al. The impact of methamphetamine/amphetamine use on receipt and outcomes of medications for opioid use disorder: a systematic review. Addict Sci Clin Pract 16, 62 (2021). https://doi.org/10.1186/s13722-021-00266-2 Abstract Background Methamphetamine...

Source: Herring AA, Vosooghi AA, Luftig J, et al. High-Dose Buprenorphine Induction in the Emergency Department for Treatment of Opioid Use Disorder. JAMA Netw Open. 2021;4(7):e2117128. doi:10.1001/jamanetworkopen.2021.17128 Key Points Question Is high-dose (>12 mg) buprenorphine induction safe and...

Source: Hser, YI., Ober, A.J., Dopp, A.R. et al. Is telemedicine the answer to rural expansion of medication treatment for opioid use disorder? Early experiences in the feasibility study phase of a National Drug Abuse Treatment Clinical Trials Network Trial. Addict Sci Clin Pract 16, 24 (2021)...

Source: Marshall, K., Maina, G. & Sherstobitoff, J. Plausibility of patient-centred care in high-intensity methadone treatment: reflections of providers and patients. Addict Sci Clin Pract 16, 42 (2021). https://doi.org/10.1186/s13722-021-00251-9 Abstract Background Patients with opioid use disorder...